SCHEMBL4572963

SCHEMBL4572963

CC(=O)/C=C/c1cncs1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NLRP3 Q96P20 1/20 0.36
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
PIM1 P11309 1/20 0.35
IAPP P10997 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 2/20 0.34
PTGS1 P23219 1/20 0.34
MEN1 O00255 1/20 0.34
KDM4E B2RXH2 3/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 2/20 0.34
GAA P10253 1/20 0.33
CYP19A1 P11511 1/20 0.32
APP P05067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4572964 1.00 GLA (0.38) GLATDP1NLRP3MAPTLMNA
SCHEMBL2522171 0.82 HCAR2 (0.48) NLRP3PIM1KMT2AKDM4ESMN1; SMN2
SCHEMBL9255626 0.80 KMT2A (0.49) NLRP3MAPTLMNAKMT2AALDH1A1
SCHEMBL9255628 0.80 KMT2A (0.49) NLRP3MAPTLMNAKMT2AALDH1A1
SCHEMBL6297811 0.80 PIK3CD (0.37) NLRP3PIM1SMN1; SMN2RAB9ACYP19A1
SCHEMBL16019162 0.76 RAB9A (0.47) MAPTLMNAKDM4EHTTRAB9A
SCHEMBL26394964 0.74 HDAC8 (0.37) NLRP3PIM1KMT2AALDH1A1CYP19A1
SCHEMBL1556671 0.74 PFKFB3 (0.53) MAPTLMNAKMT2AALDH1A1MEN1
SCHEMBL28627582 0.73
SCHEMBL14153897 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4727923-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA University of Georgia Research Foundation, Inc. (US) 2026-04-22 EP disclosed
US-20260098012-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA UNIV GEORGIA (US) 2026-04-09 US disclosed
WO-2024258904-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2024-12-19 WO disclosed
US-20080267942-A1 BENZAZEPIN-2(1H)-ONE DERIVATIVES PFIZER LIMITED (GB) 2008-10-30 US disclosed
WO-2008050207-A1 HETEROCYCLIC COMPOUNDS USEFUL AS ANABOLIC AGENTS FOR LIVESTOCK ANIMALS PFIZER LIMITED (GB) 2008-05-02 WO disclosed
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality PFIZER LIMITED (GB) 2008-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098012-A1 TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA CD47, SLC11A2, G6PD GLA 4412/4885TDP1 4043/4885NLRP3 245/4885
US-20080103130-A1 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality ADRB2, ADRB1, ADRA2C GLA 3765/4885TDP1 2966/4885NLRP3 2331/4885
US-20080267942-A1 BENZAZEPIN-2(1H)-ONE DERIVATIVES ADRB2, ADRB1, ADRA2C GLA 1776/4885TDP1 4088/4885NLRP3 3749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.